Neurocrine Biosciences (NBIX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

NBIX is expected to report earnings to fall 7.36% to $1.51 per share on October 29

Neurocrine Biosciences NBIX Stock Earnings Reports

Q3'24

Est.

$1.51

Q2'24

Beat

by $0.50

Q1'24

Beat

by $0.13

Q4'23

Beat

by $0.33

Q3'23

Beat

by $0.49

The last earnings report on August 01 showed earnings per share of $1.63, beating the estimate of $1.13. With 936.43K shares outstanding, the current market capitalization sits at 13.72B.

View a ticker or compare two or three

Compare

NBIX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NBIX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NBIX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a product based biopharmaceutical company

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12780 El Camino Real

Phone

+1 858 617-7600

Employees

1400

Web

https://www.neurocrine.com